NEW YORK, March 3, 2015 /PRNewswire/ -- Milberg LLP announces that it is investigating potential violations of the federal securities laws by Akorn, Inc. ("Akorn" or the "Company")(NASDAQ: AKRX), in connection with its public statements to investors.
On March 2, 2015 Akorn announced that "the Company filed a Form 12b-25, Notification of Late Filing with the U.S. Securities and Exchange Commission allowing the Company to extend the deadline to file its Form 10-K for the year ended December 31, 2014. The Company has experienced delays in collecting and compiling certain financial and other related data that should be included in the Form 10-K. Specifically, the delays are related to the VersaPharm and Hi-Tech Pharmacal subsidiaries which were not integrated into the Company's centralized accounting department and accounting systems as of December 31, 2014."
On this news, shares of Akorn fell $4.63 per share to $49.08, or more than 8.62%, on March 3, 2015.
If you have any information about the Company, or if you purchased Akorn shares, and you would like to learn more about this potential matter, please contact the following attorney:
Andrei Rado, Esq.
Milberg LLP
One Pennsylvania Plaza, 49th Fl.
New York, NY 10119-0165
Phone number: (800) 320-5081
Email: contactus@milberg.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/milberg-llp-is-investigating-claims-on-behalf-of-akorn-inc-akrx-investors-300044955.html
SOURCE Milberg LLP
